These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22201865)

  • 21. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.
    Persano L; Rampazzo E; Della Puppa A; Pistollato F; Basso G
    ScientificWorldJournal; 2011; 11():1829-41. PubMed ID: 22125441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review).
    Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P
    Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
    Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
    PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
    Persano L; Rampazzo E; Basso G; Viola G
    Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
    Rezaei V; Rabiee A; Khademi F
    J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening.
    O'Duibhir E; Carragher NO; Pollard SM
    Mol Cell Neurosci; 2017 Apr; 80():198-207. PubMed ID: 27825983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.
    Yang L; Lin C; Wang L; Guo H; Wang X
    Exp Cell Res; 2012 Nov; 318(19):2417-26. PubMed ID: 22906859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoamines in glioblastoma: complex biology with therapeutic potential.
    Caragher SP; Hall RR; Ahsan R; Ahmed AU
    Neuro Oncol; 2018 Jul; 20(8):1014-1025. PubMed ID: 29126252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 as a Therapeutic Target for Glioblastoma.
    Liu Y; Li C; Lin J
    Anticancer Agents Med Chem; 2010 Sep; 10(7):512-9. PubMed ID: 20879983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
    Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
    Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
    Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
    Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
    Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W
    Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging therapeutic targets and agents for glioblastoma migrating cells.
    Di C; Mattox AK; Harward S; Adamson C
    Anticancer Agents Med Chem; 2010 Sep; 10(7):543-55. PubMed ID: 20950259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel stem cell culture model of recurrent glioblastoma.
    Qazi MA; Vora P; Venugopal C; McFarlane N; Subapanditha MK; Murty NK; Hassell JA; Hallett RM; Singh SK
    J Neurooncol; 2016 Jan; 126(1):57-67. PubMed ID: 26498281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.